Full Breakdown
Speculation Surrounds President Trump's Health Amid Claims of Alzheimer's Medication Use
12/12/2025, 10:05:58 PM
Health Concerns and Speculation
Recent discussions regarding President Donald Trump's health have intensified following comments made by Congresswoman Sydney Kamlager-Dove (D-CA). Kamlager-Dove suggested that Trump, 79, may be taking Leqembi, a medication used to treat Alzheimer's disease, which costs approximately $26,500 annually. Her theory emerged after she noted visible bruising on Trump's hand, which she speculated could be linked to the drug's side effects, including swelling and the need for regular MRIs. Kamlager-Dove's remarks were prompted by a press briefing where White House Press Secretary Karoline Leavitt was questioned about Trump's health, particularly regarding his bruised hand and cognitive tests.
Official Responses and Denials
In response to Kamlager-Dove's claims, the White House issued a denial, with spokesperson Steven Cheung stating that the Congresswoman was "hallucinating" and distorting reality. Leavitt defended Trump, attributing the bruising to his frequent handshakes and a daily aspirin regimen, while also stating that the president has been meeting with numerous individuals regularly. Despite these assertions, Kamlager-Dove reiterated her concerns, highlighting Trump's visible fatigue during public appearances and his admission of undergoing three cognitive tests, which he claimed to have aced.
Observations and Symptoms
Reports indicate that Trump has displayed symptoms consistent with potential cognitive decline, including drowsiness and difficulty staying awake during events. The Alzheimer’s Association notes that individuals with a family history of Alzheimer's, such as Trump—whose father suffered from the disease—are at a higher risk. Additionally, Leqembi's side effects include fatigue and the need for regular MRI scans to monitor for complications, which has raised further questions about Trump's health following his MRI at Walter Reed Medical Center.
Criticism and Opposition
Kamlager-Dove's theory has drawn criticism from various quarters, with some labeling it as speculative and unfounded. However, she maintains that her inquiries are legitimate, stating, "Hey, I’m just asking questions." Critics argue that such speculation could be politically motivated, especially given the contentious nature of Trump's presidency and the ongoing scrutiny of his cognitive abilities.
Conflicting Reports and Gaps
While Kamlager-Dove's assertions have gained traction, the White House has consistently maintained that Trump is in "perfect overall health," as stated by his physician, Sean Barbabella. This discrepancy between public speculation and official statements highlights the ongoing debate regarding Trump's cognitive fitness and the implications of his health on his presidency.
Verbatim Quotes
- “It seems as if the Congresswoman has not been taking her medication because she is hallucinating, distorting reality in a clearly troublesome state that requires urgent medical care,” — Steven Cheung, White House Spokesperson
- “I’m not a doctor, but I do think it’s curious that [Trump’s] drowsiness and visible bruising on his hands are consistent with known symptoms and side effects of Alzheimer’s medications like Leqembi,” — Sydney Kamlager-Dove, Congresswoman
The ongoing discourse surrounding President Trump's health reflects broader concerns about transparency and accountability in political leadership, particularly as it relates to cognitive fitness and public perception.
